If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
335.00    1.50 (0.45%)
Bid:
324.50
Ask:
334.50
Spread: 10.00 (3.082%)
Market Cap: £772.74m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Directorate Change

14 Feb 2022 07:00

RNS Number : 4988B
Chesnara PLC
14 February 2022
 

CHESNARA plc

("Chesnara" or "the Company")

 

14 February 2022

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

INDEPENDENT NED APPOINTMENTS

 

Chesnara plc today announces the appointment of two new independent Non-Executive Directors, Carol Hagh and Karin Bergstein, to the Board with immediate effect. They will be proposed for election at the Company's AGM on 17 May 2022.

 

Carol will join Chesnara plc Nomination & Governance Committee and Remuneration Committee with Karin joining Chesnara plc Audit & Risk Committee and Nomination & Governance Committee.

 

Carol has had an extensive international career in the insurance sector. She was previously head of the UK insurance practice at the executive search firm Spencer Stuart. Prior to this, she held roles in strategy, customer centricity and digital innovation at Aviva in the UK and Aegon in the Netherlands. She began her career in the US as an actuarial trainee. Carol holds a BA from Harvard University and an MBA from INSEAD.

 

Karin brings a wealth of experience from a career in executive and non-executive roles. She has helped a number of listed companies develop and grow with a proven track record in M&A and (digital) transformation. Most recently these have included roles as CFO for Aidence N.V., COO of a.s.r. Nederland N.V. and various senior executive positions within ING Bank and its subsidiaries. Karin is also an experienced non-executive in financial services (BNG Bank N.V, Van Lanschot Kempen N.V.), care / pharma (Sanquin) and academic (Utrecht University) environments. Karin holds a number of undergraduate and post-graduate qualifications from institutions in the Netherlands, US and France.

 

Their appointments increase the total number of Board Directors at Chesnara, to six from five prior to the retirement of Veronica Oak in January.

 

Chairman Luke Savage commented:

'I am delighted to welcome both Carol and Karin to the Board of Chesnara. We are delighted to have attracted two highly talented individuals with such diverse expertise and experience. Their insight and skills, particularly from an international perspective, will be of significant benefit to the Group as we continue to execute on our ambitious strategy and deliver value to our policyholders and shareholders.'

 

There is no further information relating to either Carol or Karin which would require disclosure under 9.6.13R of the Listing Rules.

 

For further information, please contact:

 

 

Roddy Watt

Director, Capital Markets

FWD

Forward thinking communications

 

T - 020 7280 0651

E - roddy.watt@fwdconsulting.co.uk 

 

 

Notes to Editors

Chesnara is a life and pensions company listed on the London Stock Exchange. It administers approximately 900,000 policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

 

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 17 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATBMRTMTJBBMT
Date   Source Headline
24th Nov 20177:00 amRNSCapital Markets Day
23rd Nov 20177:30 amRNSHolding(s) in Company
23rd Nov 20177:00 amRNSResult of External Audit Tender
7th Nov 20177:00 amRNSDirector/PDMR Shareholding
1st Nov 20174:06 pmRNSTotal Voting Rights
7th Sep 20177:34 amRNSStatement re: the Legacy Review
31st Aug 20177:00 amRNSHalf-year Report
17th Aug 20174:00 pmRNSHolding(s) in Company
8th Aug 20177:00 amRNSNotice of Results
2nd Aug 20177:00 amRNSTotal Voting Rights
18th May 20177:00 amRNSResult of AGM
28th Apr 20173:26 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSAnnual Financial Report & AGM Notice
11th Apr 20172:06 pmRNSSCILDON - new name for Legal & General Nederland
6th Apr 20177:00 amRNSCompletion of LGN acquisition
31st Mar 20177:00 amRNSFinal Results
30th Mar 20175:15 pmRNSAcquisition
6th Mar 201712:11 pmRNSNotice of Results
6th Jan 20177:00 amRNSHolding(s) in Company
19th Dec 20167:00 amRNSHolding(s) in Company
16th Dec 20164:56 pmRNSUpdate on Excess Applications
16th Dec 20162:15 pmRNSHolding(s) in Company
15th Dec 20168:00 amRNSAdmission of Shares
14th Dec 20167:00 amRNSDirectorate Change
13th Dec 20164:20 pmRNS2016 EGM Results, TVR and Director Dealing
13th Dec 20167:00 amRNSResults of Placing and Open Offer
24th Nov 20165:25 pmRNSPublication of a Prospectus
24th Nov 20167:01 amRNSProposed Acquisition and Placing
22nd Nov 20167:10 amRNSStatement regarding market speculation
22nd Nov 20167:00 amRNSStatement regarding press speculation
26th Oct 20167:00 amRNSDirectorate Change
29th Sep 201610:07 amRNSHolding(s) in Company
31st Aug 20167:00 amRNSHalf-year Report
30th Aug 20167:00 amRNSHolding(s) in Company
10th Aug 201612:17 pmRNSNotice of Results
4th Jul 201610:32 amRNSHolding(s) in Company
14th Jun 20164:30 pmRNSNotification of director share interest
25th May 20161:41 pmRNSHolding(s) in Company
19th May 20167:00 amRNSAppointment of new joint broker
19th May 20167:00 amRNSDirectorate Change
19th May 20167:00 amRNSResult of AGM
28th Apr 20162:32 pmRNSDirector/PDMR Shareholding
20th Apr 20167:00 amRNSAnnual Financial Report 2015 and AGM Notice
31st Mar 20167:00 amRNSFinal Results
24th Mar 20168:45 amRNSNotice of Results
11th Mar 20163:45 pmRNSHolding(s) in Company
3rd Mar 20168:34 amRNSStatement re Legacy Review
30th Nov 20151:56 pmRNSHolding(s) in Company
19th Nov 20157:00 amRNSInterim Management Statement
13th Oct 20156:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.